681254-54-6

Basic information

• Product Name: C₅₁H₅₈N₆O₁₀
• CAS NO: 681254-54-6
• Molecular Weight: 915.056
• Mol File: 681254-54-6.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: C₅₁H₅₈N₆O₁₀(CAS DataBase Reference)
• NIST Chemistry Reference: C₅₁H₅₈N₆O₁₀(681254-54-6)
• EPA Substance Registry System: C₅₁H₅₈N₆O₁₀(681254-54-6)

Safety Data

• Hazardous Substances Data: 681254-54-6(Hazardous Substances Data)

Upstream product

• 681254-38-6 2-benzyloxycarbonylamino-3-[2-({2-[2-{[1-(2-tert-butoxycarbonylamino-4-methyl-pentanoyl)-pyrrolidine-2-carbonyl]-amino}-3-(4-hydroxy-phenyl)-propionyl]-1,2,3,4-tetrahydro-isoquinoline-3-carbonyl}-amino)-3-phenyl-propionyloxy]-butyric acid methyl ester 
• 681254-22-8 (2S,3R)-2-Benzyloxycarbonylamino-3-[(S)-2-({(R)-2-[(S)-2-tert-butoxycarbonylamino-3-(4-hydroxy-phenyl)-propionyl]-1,2,3,4-tetrahydro-isoquinoline-3-carbonyl}-amino)-3-phenyl-propionyloxy]-butyric acid methyl ester 
• 808771-73-5 (S)-2-({(R)-2-[(S)-2-tert-Butoxycarbonylamino-3-(4-hydroxy-phenyl)-propionyl]-1,2,3,4-tetrahydro-isoquinoline-3-carbonyl}-amino)-3-phenyl-propionic acid methyl ester 
• 681253-63-4 (S)-2-({(R)-2-[(S)-2-tert-Butoxycarbonylamino-3-(4-hydroxy-phenyl)-propionyl]-1,2,3,4-tetrahydro-isoquinoline-3-carbonyl}-amino)-3-phenyl-propionic acid 
• 500213-40-1 3-(1-methoxycarbonyl-2-phenyl-ethylcarbamoyl)-3,4-dihydro-1H-isoquinoline-2-carboxylic acid tert-butyl ester 
• 617688-33-2 (S)-3-Phenyl-2-[((R)-1,2,3,4-tetrahydro-isoquinoline-3-carbonyl)-amino]-propionic acid methyl ester 
• 64205-66-9 (tert-butoxycarbonyl)-L-leucyl-L-proline 
• 78879-20-6 D-N-tert-butoxycarbonyl-1,2,3,4-tetrahydroisoquinolinoline-3-carboxylic acid 
• 68624-06-6 (S)-methyl 1-((S)-2-(tert-butoxycarbonylamino)-4-methylpentanoyl)pyrrolidine-2-carboxylate 
• 2577-48-2 methyl (2S)-pyrrolidine carboxylate 
• 2577-90-4 methyl (2S)-2-amino-3-phenylpropanoate 
• 13139-15-6 N-tert-butoxycarbonyl-L-leucine 

Relevant articles and documents

A progressive synthetic strategy for class B synergimycins

Described are the syntheses of four macrocyclic peptides that are the core structure of class B synergimycins, and the synthesis of a final class B derivative. Our synthetic route to these synergimycin derivatives allows the incorporation of amino acid su